ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2026-33933

OpenEMR is a free and open source electronic health records and medical practice management application.

Published Mar 26, 2026 · catalog updated Jun 17, 2026 · OpenEMR is a free

Check if you run it

No confirmed exploitation is on record for CVE-2026-33933. EPSS is 0.92%. Act only if a listed version of OpenEMR is a free is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (OpenEMR is a free).
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium6.1
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.92%
Remediation
Advisory link
Affected products
cpe open-emr/openemr

OpenEMR is a free and open source electronic health records and medical practice management application. Starting in version 7.0.2.1 and prior to version 8.0.0.3, a reflected cross-site scripting (XSS) vulnerability in the custom template editor allows an attacker to execute arbitrary JavaScript in an authenticated staff member's browser session by sending them a crafted URL. The attacker does not need an OpenEMR account. Version 8.0.0.3 patches the issue.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe open-emr/openemrversion unspecified

How to fix CVE-2026-33933

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-33933. EPSS is 0.92%. Act only if a listed version of OpenEMR is a free is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-79: Cross-site Scripting (XSS). EPSS 0.92%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

Timeline

Detection, updates, and resolution for this record.

  1. Mar 26, 2026 · NIST NVD

    Detected

    OpenEMR is a free and open source electronic health records and medical practice management application. Starting in version 7.0.2.1 and prior to version 8.0.0.3, a reflected cross-site scripting (XSS) vulnerability in the custom template editor allows an attacker to execute arbitrary JavaScript in an authenticated staff member's browser session by sending them a crafted URL. The attacker does not

  2. Jun 17, 2026 · NIST NVD

    Updated

    OpenEMR is a free and open source electronic health records and medical practice management application. Starting in version 7.0.2.1 and prior to version 8.0.0.3, a reflected cross-site scripting (XSS) vulnerability in the custom template editor allows an attacker to execute arbitrary JavaScript in an authenticated staff member's browser session by sending them a crafted URL. The attacker does not

Sources

  • CVE.orgVulnerability recordCVE-2026-33933

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-33933

    30-day exploitation probability 0.9%

    first.org
  • NIST NVDVulnerability recordCVE-2026-33933

    OpenEMR is a free and open source electronic health records and medical practice management application. Starting in version 7.0.2.1 and prior to version 8.0.0.3, a reflected cross-site scripting (XSS) vulnerability in the custom template editor allows an attacker to execute arbi

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.